Lymphoproliferative disorders Clinical Trials

US Oncology - Providence Health System, Site #167
Burbank California 91505
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

City of Hope
Duarte California 91010-3000

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

University of California Los Angeles
Los Angeles California 90095-1678

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

UCLA Department of Medicine, Site #027
Los Angeles California 90095
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Bay Area Cancer Research Group, Site #156
Pleasant Hill California 94523
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Children's Hospital Denver
Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Rocky Mountain Cancer Centers, Site #191
Boulder Colorado 80303
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Cancer Center of Central Connecticut, Site #147
Southington Connecticut 06489
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Christiana Care Health Services, Site #155
Newark Delaware 19713
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University Cancer Institute, Site #149
Boynton Beach Florida 33426
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Florida Cancer Specialists, Site #180
Fort Myers Florida 33916
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Florida Cancer Specialists, Site #179
St. Petersburg Florida 33705
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Winship Cancer Institute of Emory University
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Children's Healthcare of Atlanta at Egleston
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Emory University, Site #058
Atlanta Georgia 30322
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Georgia Health Sciences University
Augusta Georgia 30912-3125
Updated

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Northwestern University
Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Rush University Medical Center
Chicago Illinois 60612

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

University of Chicago
Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

John H. Stroger, Jr. Hospital of Cook County, Site #192
Chicago Illinois 60612
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of Chicago, Site #001
Chicago Illinois 60637
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Franciscan St. Francis Health, Site #138
Indianapolis Indiana 46237
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of Iowa Hospitals and Clinics, Site #050
Iowa City Iowa 52242
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Siouxland Hematology-Oncology Associates, Site #198
Sioux City Iowa 51101
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

US Oncology - Cancer Center of Kansas, Site #168
Wichita Kansas 67214
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Willis-Knighton Cancer Center, Site #196
Shreveport Louisiana 71103
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

St. Agnes Healthcare, Site #185
Baltimore Maryland 21229
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of Maryland, Greenebaum Cancer Center, Site #040
Baltimore Maryland 21201
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Greater Baltimore Medical Center, Site #140
Baltimore Maryland 21204
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical research study of bortezomib and rituximab for the treatment of Post-transplant Lymphoproliferative Disease, Solid Organ Transplant, Stem Cell Transplant (Bone Marrow Transplant) or Epstein Barr Virus Infections

Dana Farber Institute
Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Massachusetts General Hospital, Site #047
Boston Massachusetts 02114
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Dana Farber Cancer Institute, Site #008
Boston Massachusetts 02215
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of Massachusetts Worcester, Site #152
Worcester Massachusetts 01655
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of Michigan Medical Center, Site #011
Ann Arbor Michigan 48109
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Barbara Ann Karmanos Cancer Institute
Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Detroit Clinical Research Center, PC
Novi Michigan 48377
Updated

Patients are needed to participate in a clinical research study of Pralatrexate Injection to evaluate Peripheral T-cell Lymphoma

Providence Cancer Institute, Site #197
Southfield Michigan 48075
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Mayo Clinic
Rochester Minnesota 55905

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Mayo Clinic, Site #044
Rochester Minnesota 55905
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Oncology Research Park Nicollet Institute, Site #195
St. Louis Park Minnesota 55426
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Saint Luke's Hospital, Site #162
Kansas City Missouri 64111
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Mercy Clinic - Cancer & Hematology, Site #151
Springfield Missouri 65804
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

Washington University School of Medicine
St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating Blinatumomab for the treatment of Acute Lymphoblastic Leukemia

Nebraska Hematology-Oncology, P.C., Site # 133
Lincoln Nebraska 68506
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

US Oncology - Comprehensive Cancer Center of Nevada, Site #169
Las Vegas Nevada 89169
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

John Theurer Cancer Center, Site #128
Hackensack New Jersey 07601
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia

University of New Mexico Cancer Center, Site #166
Albuquerque New Mexico 87106
Updated

Patients are needed to participate in a clinical research study evaluating ponatinib and imatinib (Gleevec/ Glivec) for the treatment of Chronic Myeloid Leukemia